A 72-year-old woman with chronic obstructive pulmonary disease (COPD, FEV₁ 35% predicted) and severe osteoarthritis pain presents to the emergency department with acute dyspnea (RR 28/min, SpO₂ 88% on room air, PaCO₂ 58 mmHg). Her daughter reports that she took 'extra painkillers' 3 hours ago—specifically, she self-administered two 10 mg morphine immediate-release tablets instead of her usual one. Examination reveals pinpoint pupils, drowsiness, and absent bowel sounds. What is the most appropriate immediate management?

Explanation

## Opioid Overdose Management **Key Point:** Opioid overdose is a medical emergency. Naloxone (a competitive opioid antagonist) is the definitive antidote and must be given immediately. Respiratory depression, pinpoint pupils, and altered consciousness are classic signs of opioid toxicity. ### Clinical Presentation of Opioid Overdose The triad of opioid overdose: 1. **Respiratory depression** (RR <8/min, SpO₂ <90%, hypercapnia) 2. **Pinpoint pupils** (miosis) 3. **Altered mental status** (drowsiness, coma) This patient has all three, plus a clear history of opioid overdose (doubled morphine dose). ### Why Naloxone Is the Correct Answer **Naloxone 0.4 mg IV bolus, repeated every 2–3 minutes up to 10 mg if needed, followed by continuous infusion** is the gold standard because: 1. **Rapid onset**: IV naloxone acts within 1–2 minutes 2. **Competitive antagonism**: Displaces morphine from μ-opioid receptors, reversing respiratory depression and CNS depression 3. **Short half-life** (60–90 minutes): Requires continuous infusion or repeated dosing because morphine's half-life (2–4 hours) exceeds naloxone's; without infusion, the patient may re-sedate as naloxone is metabolized 4. **Titration**: Start with 0.4 mg IV; if no response in 2–3 minutes, double the dose and repeat up to 10 mg 5. **Infusion protocol**: After initial bolus response, start continuous IV infusion at 0.4–0.8 mg/hour (or 2/3 of the effective bolus dose per hour) to maintain antagonism **High-Yield:** Naloxone is a **pure competitive antagonist** with no intrinsic activity; it does not cause respiratory depression even at high doses. ### Mechanism of Action ```mermaid flowchart TD A[Opioid overdose<br/>Morphine occupies μ-receptors]:::outcome --> B[Respiratory depression<br/>CNS depression<br/>Miosis]:::urgent B --> C[Naloxone IV bolus]:::action C --> D[Naloxone competitively displaces morphine<br/>from μ-opioid receptors]:::action D --> E{Respiratory depression reversed?}:::decision E -->|Yes| F[Start continuous IV infusion<br/>0.4-0.8 mg/hour]:::action E -->|No| G[Repeat bolus every 2-3 min<br/>up to 10 mg total]:::action G --> E F --> H[Monitor for 4-6 hours<br/>Watch for re-sedation]:::action ``` ### Why Other Options Are Wrong | Option | Why Not | |--------|--------| | **Mechanical ventilation alone (no naloxone)** | Supportive care is necessary but insufficient. Naloxone is the definitive treatment; withholding it prolongs opioid toxicity and delays recovery. The fear of "acute withdrawal" is overblown—naloxone causes mild withdrawal symptoms (agitation, sweating) but these are far less dangerous than respiratory arrest. | | **Flumazenil** | Flumazenil is a benzodiazepine antagonist, not an opioid antagonist. It is irrelevant here and may precipitate seizures if benzodiazepines are co-ingested. | | **Naltrexone 50 mg PO** | Naltrexone is a long-acting opioid antagonist (half-life 10–13 hours) used for opioid-use disorder maintenance, not acute overdose. Oral administration is too slow; IV naloxone is required for emergency reversal. | **Clinical Pearl:** Acute withdrawal from naloxone (agitation, tachycardia, hypertension, diaphoresis) is uncomfortable but not life-threatening. Respiratory depression from opioid overdose is immediately fatal. Always choose naloxone. ### Management Algorithm 1. **Immediate**: Naloxone 0.4 mg IV bolus 2. **If no response in 2–3 min**: Repeat 0.4 mg IV; may escalate to 0.8 mg, then 1.6 mg, up to 10 mg total 3. **After response**: Start continuous IV infusion at 0.4–0.8 mg/hour 4. **Supportive care**: Oxygen (target SpO₂ >90%), consider intubation if respiratory depression severe 5. **Monitoring**: Observe for ≥4–6 hours (longer if long-acting opioids like methadone involved) 6. **Discharge**: Educate on overdose risk, offer opioid-use disorder treatment or naloxone auto-injector for home use **Warning:** Do NOT withhold naloxone out of fear of withdrawal. Respiratory depression kills; withdrawal does not. **Mnemonic: NALOXONE RESCUE** — **N**aloxone IV, **A**ntagonist (competitive), **L**ow half-life (requires infusion), **O**pioid receptors (μ-selective), **X**-out opioid effect, **O**ne bolus then infusion, **N**o flumazenil, **E**mergency antidote.